Saniona
Saniona's CEO to BioStock: "SAN2355 is a highly promising candidate for commercialization"
Read the full interview with Thomas Feldthus at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Datum | 2024-10-03, kl 09:45 |
Källa | Cision |
![](https://static.allaaktier.se/ads/avanza_inverted.png)
Investeringar innebär en risk